Stock Taper
PRFX
PRF TECHNOLOGIES LTD.
NASDAQ
$1.00
▼ DOWN 0.29% (-0.00)

KEY STATISTICS

Market Cap$80.30 K
52w High$9.60
52w Low$0.91
Dividend Yield
Frequency
P/E-0.01
Volume67.99K
Shares Out.80.53K

COMPANY

LEADERSHIP

Efraim Cohen-Arazi
CHIEF EXECUTIVE
Efraim Cohen-Arazi

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 1, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7

SPLIT RECORD

DATETYPERATIO
2026-02-06Reverse1:5
2026-02-05Reverse1:5
2024-11-21Reverse1:4
2024-09-09Reverse1:6
2023-07-03Reverse1:10

PRICE

$1.00 ▼ DOWN 0.29% (−$0.00)
OVERLAYS
$0.98$1.00$1.02$1.049:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM1.00

About PRF Technologies Ltd.

https://www.painreform.com ↗

PRF Technologies Ltd. is an Israeli clinical-stage pharma company developing PRF-110, a long-acting post-surgical pain relief solution currently in Phase 3 trials for bunionectomy and hernia repair.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A SERVICE PRF TECHNOLOGIES LTD. IS KNOWN FOR

DeepSolar Smart TDD

PRF Technologies' AI-driven solar analytics service offers technical due diligence for utility-scale solar plants, highlighting its focus on renewable energy and recent commercial agreements.

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

DIRECTOR, OFFICER: INTERIM CEO
Cohen-Arazi Efraim
· 150 shares
2026-03-18
DIRECTOR, OFFICER: INTERIM CEO
Cohen-Arazi Efraim
· 183 shares
2026-03-18
OFFICER: CHIEF FINANCIAL OFFICER
Broder Eyal
· 180 shares
2026-03-18
OFFICER: CHIEF FINANCIAL OFFICER
Broder Eyal
· 2.0K shares
2026-03-18

SECTORS PEERS

PEERPRICE
VRAX$3.19COMPARE
UPC$5.30COMPARE
ELAB$6.66COMPARE
NCEL$3.26COMPARE
DRMA$1.42COMPARE
ATXI$0.26COMPARE
NKGN$0.01COMPARE
XRTX$2.04COMPARE